Atypical Endometrial Hyperplasia
📧 Sign up to get email alerts when something new happens for Atypical Endometrial Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer (Phase 1)
This clinical trial update describes a Phase 1 study (SHAPE-ENDO) evaluating multimodal pre-surgical optimization for patients with obesity …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
A Mayo Clinic-sponsored clinical trial is evaluating methylated DNA markers to detect endometrial, ovarian, and cervical cancers, with recru…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Intrauterine Injection of Type III Collage in FST of EC/AEH [Phase 2]
Phase 2 clinical trial evaluating intrauterine injection of Type III collagen for endometrial cancer and atypical endometrial hyperplasia; c…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the levonorgestrel-releasing intrauterine system with or without everolimus to treat atypical endomet…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy [Phase 2]
Phase 2 clinical trial evaluating Megestrol Acetate with or without Pterostilbene in patients with endometrial cancer undergoing hysterectom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating the combination of a GnRH agonist with letrozole in obese women with progestin-insensitive en…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients [Phase 2, Phase 3]
An ongoing Phase 2/3 trial evaluating a gonadotropin-releasing hormone agonist combined with letrozole for obese patients with progestin-ins…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients [Phase 2, Phase 3]
This is a Phase 2/3 clinical trial assessing a gonadotropin-releasing hormone agonist together with letrozole for non-obese, progestin-insen…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia [Phase 2, Phase 3]
The document reports a Phase 2/3 clinical trial update that is currently recruiting, testing a weight-management approach combined with LNG-…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Ultrasound and Histology in AEH and Early EEC Treated Conservatively
A clinical trial update about a fertility-sparing treatment study evaluating ultrasound and histology in atypical endometrial hyperplasia an…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating a progesterone-based therapeutic regimen combined with statins for young women with early endometrial carc…
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating liraglutide plus megestrol acetate for endometrial atypical hyperplasia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating metformin plus megestrol acetate as a fertility-sparing treatment for atypical endometrial hyperplasia…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating medroxyprogesterone acetate plus atorvastatin in young women with atypical endometrial hyperplasia or earl…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells [NA]
This clinical trial update describes a study evaluating CA-IX, p16, proliferative markers, and HPV to diagnose cervical lesions in patients …
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia [Phase 2, Phase 3]
A clinical trial evaluating megestrol acetate plus rosuvastatin in young women with atypical endometrial hyperplasia has completed phases 2 …
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing LVN-IUS to oral megestrol acetate for atypical endometrial hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial investigating LNG-IUS as a fertility-preserving treatment for endometrial cancer and atypical endometrial hyp…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate [Phase 2]
Phase 2 study evaluating megestrol acetate for management of atypical endometrial hyperplasia and endometrial carcinoma. Results were posted…
-
CLINICAL_TRIALS withdrawal · 2014-09-10Clinical Trial Update: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer [Phase 2]
This Phase 2 trial evaluating Megestrol acetate or levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia or endo…